Toronto Dominion Bank Purchases Shares of 20,000 Liquidia Co. (NASDAQ:LQDA)

Toronto Dominion Bank acquired a new position in shares of Liquidia Co. (NASDAQ:LQDA - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 20,000 shares of the company's stock, valued at approximately $235,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Catalina Capital Group LLC lifted its stake in shares of Liquidia by 6.5% in the 4th quarter. Catalina Capital Group LLC now owns 18,307 shares of the company's stock valued at $215,000 after purchasing an additional 1,125 shares during the last quarter. Rhumbline Advisers boosted its position in Liquidia by 3.5% in the fourth quarter. Rhumbline Advisers now owns 80,652 shares of the company's stock valued at $948,000 after buying an additional 2,741 shares in the last quarter. Sigma Planning Corp lifted its position in shares of Liquidia by 3.4% during the fourth quarter. Sigma Planning Corp now owns 65,210 shares of the company's stock worth $767,000 after purchasing an additional 2,115 shares in the last quarter. Bank of New York Mellon Corp lifted its position in shares of Liquidia by 3.3% during the fourth quarter. Bank of New York Mellon Corp now owns 188,584 shares of the company's stock worth $2,218,000 after purchasing an additional 6,034 shares in the last quarter. Finally, Steward Partners Investment Advisory LLC acquired a new position in Liquidia in the fourth quarter valued at approximately $59,000. 64.54% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Liquidia

In other Liquidia news, insider Jason Adair sold 1,856 shares of the business's stock in a transaction on Monday, April 14th. The stock was sold at an average price of $13.57, for a total transaction of $25,185.92. Following the transaction, the insider now owns 184,304 shares of the company's stock, valued at approximately $2,501,005.28. The trade was a 1.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Roger Jeffs sold 14,130 shares of the company's stock in a transaction on Monday, April 14th. The shares were sold at an average price of $13.57, for a total value of $191,744.10. Following the completion of the transaction, the chief executive officer now directly owns 1,006,420 shares in the company, valued at approximately $13,657,119.40. This trade represents a 1.38% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,138 shares of company stock worth $450,233 over the last three months. 26.50% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on the stock. HC Wainwright increased their price objective on shares of Liquidia from $29.00 to $35.00 and gave the stock a "buy" rating in a research report on Wednesday, May 28th. Wells Fargo & Company raised their price target on shares of Liquidia from $20.00 to $23.00 and gave the stock an "overweight" rating in a research report on Wednesday, May 28th. Oppenheimer set a $13.00 target price on shares of Liquidia and gave the company an "underperform" rating in a report on Monday, May 19th. Needham & Company LLC reaffirmed a "buy" rating and set a $25.00 price target on shares of Liquidia in a report on Wednesday, May 28th. Finally, BTIG Research restated a "buy" rating on shares of Liquidia in a research report on Tuesday, May 27th. One analyst has rated the stock with a sell rating, one has issued a hold rating, six have given a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $26.67.

Liquidia Stock Up 2.4%

Shares of Liquidia stock traded up $0.42 during trading hours on Thursday, reaching $18.02. 2,891,924 shares of the stock traded hands, compared to its average volume of 1,119,879. The company has a 50 day moving average price of $14.89 and a 200 day moving average price of $13.92. The firm has a market capitalization of $1.54 billion, a price-to-earnings ratio of -11.06 and a beta of 0.24. Liquidia Co. has a one year low of $8.26 and a one year high of $19.41.

Liquidia (NASDAQ:LQDA - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported ($0.45) earnings per share for the quarter, missing analysts' consensus estimates of ($0.42) by ($0.03). Liquidia had a negative return on equity of 163.21% and a negative net margin of 765.38%. The business had revenue of $3.12 million during the quarter, compared to analysts' expectations of $3.23 million. Sell-side analysts anticipate that Liquidia Co. will post -1.51 earnings per share for the current year.

Liquidia Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).